Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure

摘要

BackgroundExisting clinical trial data do not address whether all angiotensin-converting-enzyme (ACE) inhibitors are similarly beneficial in improving survival and reducing the rate of readmission among patients with congestive heart failure. We sought to answer this question using administrative databases from Canada's 3 most populous provinces.